Subject: Big Update from TRTC

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
Big Update from TRTC
Hot Stock to WatchHot Stock to Watch

Company: Terra Tech Corp (OTCQX: TRTC)


Last:

Price: 0.3648

Change (%): + 0.0156 (4.47)

Volume: 906,257
TRTC Chart

Terra Tech Releases Update on Blüm Oakland Dispensary

NEWPORT BEACH, Calif., June 20, 2016 /PRNewswire/ - Terra Tech Corp. (OTCQX: TRTC) (“Terra Tech” or the “Company”), a vertically-integrated, cannabis-focused agriculture company, today announced a corporate update on its Blüm dispensary, located in Oakland, California and provided visibility into the progress of the Company strategy surrounding retail dispensaries. Sales of concentrates increased 42% in May 2016, compared to January 2016, driven by higher sales of Terra Tech’s own-brand of IVXX concentrates. Sales from concentrates are the third largest contributor to Blüm Oakland revenue and are a significant growth vertical for Terra Tech.

Blüm Oakland is Terra Tech’s high-volume, retail storefront, offering a range of flowers, edibles and concentrates to patients in the Bay Area of San Francisco. It holds over 42,000 registered patients and services close to 1,000 patients each day. Blüm Oakland also has a fully integrated supply chain, which consists of a sophisticated onsite cultivation facility and a portfolio of proprietary strains.

“The Blüm Oakland dispensary has displayed strong momentum since we completed the acquisition on March 31, 2016, with our diverse and expanded product lines of medical cannabis products proving to be a hit with patients,” commented Derek Peterson, Terra Tech CEO. “In particular, the ‘Whoopi & Maya’ line of cannabis products for menstrual cramp pain by Whoopi Goldberg has attracted female patients looking for all-natural products to alleviate discomfort. Our Half Caked edible products have also been flying off the shelves, particularly the caramel popcorn and tainted butter are a huge hit that keep selling out upon arrival. Furthermore, our cultivated strain of Girl Scout Cookies is at a phenomenal level of quality we haven’t seen to date, proving popular with patients looking for a high quality and potent product.

“Our Oakland store had a 42% increase in sales of concentrates, which is the fastest growing product line in the medical cannabis space. Most excitingly, 46% of the concentrates sold at Blüm Oakland in April and May were from our proprietary line of IVXX-branded medical cannabis products, up from 6% in January of this year. This reflects our strategy to dominate the medical cannabis market and establish ourselves as leaders in every stage of the cannabis lifecycle - from cultivation and production to retail. We’ve built a strong model for success based on our leading brands, and the Blüm Oakland retail location will serve as a blueprint for our other dispensaries in Nevada, giving us confidence in our long-term growth plan,” concluded Mr. Peterson.

Continue Reading

Like Us on FacebookFollow Us on Twitter

IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks